Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment - Schwarzbich, Mark-Alexander; Schöning, Tilman; Cremer, Martin; Kriegsmann, Katharina; Ho, Anthony Dick; Witzens-Harig, Mathias (Leukemia and lymphoma, 2016)
Gesehen am 26.05.2020